Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Spengler

Showing results (131-140 of 192) with videos related to

Pageof 20
Sort By:
European Journal of Medical Research|July 30, 1999
Failure of double protease inhibitor therapy as a salvage therapy for HIV-infected patients resistant to conventional triple therapyJ K Rockstroh, M Altfeld, B Kupfer, et al.
Hepatology (Baltimore, Md.)|June 1, 1997
The low-dose monoethylglycinexylidide test: assessment of liver function with fewer side effectsC Reichel, A Nacke, T Sudhop, et al.
European Journal of Medical Research|May 12, 2000
Indication, outcome and follow up of intensive care in patients with HIV-infectionL Leifeld, J Rockstroh, S Skaide, et al.
Gastroenterology|August 10, 2000
Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failureK Streetz, L Leifeld, D Grundmann, et al.
The Journal of Pathology|August 28, 2001
Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitisL Leifeld, J Ramakers, A M Schneiders, et al.
Digestion|September 11, 2001
Transient loss of T-cell reactivity in a patient with hepatitis C virus reinfectionU Düesberg, O Geulen, A M Schneiders, et al.
Cytometry|November 21, 2000
Flow cytometric analysis of peptide binding to major histocampatibility complex class I for hepatitis C virus core T-cell epitopesS Schweitzer, A M Schneiders, B Langhans, et al.
European Journal of Medical Research|April 11, 2000
A hepatitis C virus (HCV) core protein derived peptide inhibits HCV specific lymphocyte proliferationB Langhans, M Lechmann, H Ihlenfeldt, et al.
European Journal of Medical Research|June 19, 2008
Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism - a reason for glycemic controlS C Blass, S Ellinger, M Vogel, et al.
European Journal of Medical Research|November 18, 2004
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysisB Terjung, F Bogsch, R Klein, et al.
Pageof 20

Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
European Journal of Medical Research|July 30, 1999
Failure of double protease inhibitor therapy as a salvage therapy for HIV-infected patients resistant to conventional triple therapyJ K Rockstroh, M Altfeld, B Kupfer, et al.
Hepatology (Baltimore, Md.)|June 1, 1997
The low-dose monoethylglycinexylidide test: assessment of liver function with fewer side effectsC Reichel, A Nacke, T Sudhop, et al.
European Journal of Medical Research|May 12, 2000
Indication, outcome and follow up of intensive care in patients with HIV-infectionL Leifeld, J Rockstroh, S Skaide, et al.
Gastroenterology|August 10, 2000
Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failureK Streetz, L Leifeld, D Grundmann, et al.
The Journal of Pathology|August 28, 2001
Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitisL Leifeld, J Ramakers, A M Schneiders, et al.
Digestion|September 11, 2001
Transient loss of T-cell reactivity in a patient with hepatitis C virus reinfectionU Düesberg, O Geulen, A M Schneiders, et al.
Cytometry|November 21, 2000
Flow cytometric analysis of peptide binding to major histocampatibility complex class I for hepatitis C virus core T-cell epitopesS Schweitzer, A M Schneiders, B Langhans, et al.
European Journal of Medical Research|April 11, 2000
A hepatitis C virus (HCV) core protein derived peptide inhibits HCV specific lymphocyte proliferationB Langhans, M Lechmann, H Ihlenfeldt, et al.
European Journal of Medical Research|June 19, 2008
Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism - a reason for glycemic controlS C Blass, S Ellinger, M Vogel, et al.
European Journal of Medical Research|November 18, 2004
Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysisB Terjung, F Bogsch, R Klein, et al.
Pageof 20